Peer-reviewedCC BYCureus
Comparative Efficacy of Ritlecitinib, Baricitinib, and Upadacitinib in Adolescents With Severe Alopecia Areata: A Bayesian Network Meta‑Analysis
- 1Biomedical Sciences, West Career and Technical Academy, Las Vegas, USA
- 2General, Surgical, and Cosmetic Dermatology, Thomas Dermatology, Las Vegas, USA
- 3Dermatology, University of Missouri Kansas City School of Medicine, Kansas City, USA
Related
- Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study
- Baricitinib Efficacy Through 4 Years in Responders and Safety up to 5 Years in Adults with Severe Alopecia Areata: Final Results from BRAVE-AA1 and BRAVE-AA2
- Cross-cultural adaptation and initial psychometric evaluation of the fruit and vegetable self-efficacy scales among secondary school adolescents in Selangor, Malaysia
- Comparative policy analysis of national frameworks for the prevention of non-communicable diseases and injuries in children and adolescents
- Comparative Efficacy of Treatments for Resistant or Uncontrolled Hypertension : A Network Meta-Analysis of Randomized Trials
BibTeX
@article{babul2026comparative,
title = {{Comparative Efficacy of Ritlecitinib, Baricitinib, and Upadacitinib in Adolescents With Severe Alopecia Areata: A Bayesian Network Meta‑Analysis}},
author = {Arya Babul and Devina Mehta and Yssra Soliman and Anand Rajpara},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13675079},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative Efficacy of Ritlecitinib, Baricitinib, and Upadacitinib in Adolescents With Severe Alopecia Areata: A Bayesian Network Meta‑Analysis
AU - Arya Babul
AU - Devina Mehta
AU - Yssra Soliman
AU - Anand Rajpara
PY - 2026
DA - 2026/10/19
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13675079
SN - 2168-8184
ER -